Poly(ADP-ribosyl)ation (PARylation) is a NAD + -dependent protein modification carried out by PARP [poly(ADP-ribose) polymerase] enzymes. Here we set out to investigate whether PARylation regulates UVB-induced cell death in primary human keratinocytes. We used the benchmark PARP inhibitor 3-aminobenzamide (3AB) and a more potent and specific inhibitor PJ34 and found that UVB (0.05-0.2 J/cm 2 ) induced a dose dependent loss of viability that was prevented by 3AB but not by PJ34. Similarly to PJ34, two other new generation PARP inhibitors also failed to protect keratinocytes from UVB-induced loss of viability. Moreover, silencing PARP-1 in HaCaT human keratinocytes sensitized cells to UVB toxicity but 3AB provided protection to both control HaCaT cells and to PARP-1 silenced cells indicating that the photoprotective effect of 3AB is independent of PARP inhibition. Lower UVB doses (0.0125-0.05 J/cm 2 ) caused inhibition of proliferation of keratinocytes which was prevented by 3AB but augmented by PJ34. UVB-induced keratinocyte death displayed the characteristics of both apoptosis (morphology, caspase activity, DNA fragmentation) and necrosis (morphology, LDH release) with all of these parameters being inhibited by 3AB and apoptotic parameters slightly enhanced by PJ34. UVA also caused apoptotic and necrotic cell death in keratinocytes with 3AB protecting and PJ34 sensitizing cells to UVA-induced toxicity. 3AB prevented UVB-induced mitochondrial membrane depolarization and generation of hydrogen peroxide. In summary, PARylation is a survival mechanism in UV-treated keratinocytes. Moreover, 3-aminobenzamide is photoprotective and acts by a PARP-independent mechanism at a premitochondrial step of phototoxicity.
Introduction
The human skin is exposed to solar ultraviolet radiation which contributes to the increasing incidence of skin tumors such as basal and squamous cell carcinoma and melanoma [1, 2] . Whereas the short wavelength UVC is effectively filtered out by the ozone layer, UVB and UVA reach the Earth surface and get absorbed in the skin. The biological effects of UV radiation in the skin depend on the type and dose of UV radiation (UVR) and range from the induction of pigmentation, vitamin D synthesis and immunosuppression to photoaging and carcinogenesis [3, 4] . In addition to amino acids, various metabolites and trans-urocanic acid, DNA is also among the molecules absorbing the energy of UV radiation in the skin [5] . UV-induced photoproducts such as cyclobutane pyrimidine dimers (CPD) and photoproducts as well as oxidative stress-induced secondary products such as 8-oxo-deoxyguanine activate DNA repair, apoptosis (sunburn cell formation) and mediate immunosuppression and inflammation [5, 6] .
Poly(ADP-ribosyl)ation (PARylation) is a NAD + -dependent covalent protein modification [7] that may regulate the biological response of the skin to UVR. PARylation is carried out by poly(ADP-ribose) polymerase (PARP) enzymes with PARP-1 and PARP-2 being the most prominent DNA break-activated members of the PARP family. The nuclear proteins PARP-1 and PARP-2 are important DNA damage sensors and upon binding to broken DNA they cleave NAD + into nicotinamide and ADP-ribose and covalently attach the latter to themselves (auto-PARylation) or to other suitable target proteins (trans-PARylation). By repeated NAD + cleavage and ADP-ribose attachment they elongate the chain to form a branched PAR polymer [7, 8] . PAR is rapidly degraded by PAR glycohydrolase (PARG) [9, 10] . Reversible PARylation is now recognized as an important form of posttranslational protein modification mediating various cellular processes ranging from DNA repair, transcriptional regulation and protein turnover to various forms of cell death [7, [10] [11] [12] .
PARylation has previously been implicated in various skin diseases [13] . PARP-1 is an important mediator of contact hypersensitivity as indicated by the anti-inflammatory effects of PARP inhibition or the PARP-1 −/− phenotype [14, 15] . Furthermore, sulfur mustard-induced vesication was proposed to be mediated by PARP activation [16] . Moreover, differential expression of PARP-1 and the PAR polymer in malignant melanomas has been shown to correlate with the clinical stage and disease-free survival of the patients [17, 18] . However, little information is available on the role of PARylation in the regulation of the UV response in keratinocytes. Here we show that only very high doses (2-4 J/cm 2 ) of UVB activate PARP in human keratinocytes. Interestingly, the benchmark PARP inhibitor 3-aminobenzamide protected keratinocytes from UVB and UVA-induced apoptotic and necrotic cell death but this protective effect was independent of PARP inhibition and is related to prevention of mitochondrial dysfunction and inhibition of ROS (reactive oxygen species) production.
Materials and methods

Cell culture
Cryopreserved normal human keratinocytes were purchased from CELLnTEC (Bern, Switzerland), and cultured in PCT Epidermal Keratinocyte Medium (low bovine pituitary extract and low calcium formulation) supplemented with 5% penicillin-streptomycin (Lonza, Basel, Switzerland). Cells were maintained at 37°C in a humidified atmosphere (5% CO 2 ), and were passaged at 80-90% confluency after trypsinization with trypsin-EDTA solution (Sigma-Aldrich, St. Louis, MO). Second and third passage cells were used for experiments.
HaCaT spontaneously immortalized keratinocyte cells were cultured in DMEM (Sigma-Aldrich, St. Louis, MO) supplemented with 10% heatinactivated fetal bovine serum, 5% penicillin-streptomycin (Lonza, Basel, Switzerland) and 5%, L-glutamine.
Gene silencing
SMARTpool siRNA specific for human PARP-1 sequence was obtained from Dharmacon Research, Inc. (Lafayette, CO). SiGLO RISC-Free siRNA (Dharmacon) was used as control. HaCaT cells were seeded into 12-well plates (2 × 10 5 cells/well) and into 96 well plates (5000 cells/well) the day before transfection in DMEM containing 10% FBS without antibiotics. DharmaFECT 2 transfection reagent (Dharmacon) was diluted 1:100 in serum free DMEM and incubated at room temperature for 5 min. In parallel, 10 μM siRNA in 1 × siRNA buffer (Dharmacon) was diluted 1:1 in serum-free DMEM and were incubated for 20 min at room temperature prior to addition to cells with a final siRNA concentration of 50 nM. After 72 h, the medium was replaced with complete growth medium. After another 24 h, efficiency of silencing was determined from 12-well plates by Western blotting [19] and cells in 96-well plates were used for the viability assay.
Cell treatments and UV irradiation
In the experiments the cells were pretreated for 30 min with two different PARP inhibitors, 10 μM PJ34 (Inotek Corporation, Beverly, MA) and 3 mM 3-aminobenzamide (Sigma-Aldrich, St. Louis, MO). In one experiment other potent PARP inhibitors thieno [2,3-c] isoquinolin-5-one (TIQ-A) and 3,4-dihydro-5-[4-(1piperidinyl)butoxyl]-1(2H)-isoquinolinone (DPQ) (all of them purchased from Axxora, Lause, Switzerland) were also used in 10 μM concentration. The cells were irradiated with the Bio-Sun microprocessor-controlled UV irradiation system (Wilber Lourmat, Marne-la-Vallée, France). The equipment operates at two wavelengths: 312 nm (UVB) and 365 nm (UVA) and is equipped with a built-in UV sensor. The irradiation stops automatically when the energy received matches the programmed energy. The primary keratinocytes were irradiated in the culture medium with different doses of UVB (0.05 J/cm 2 -0.2 J/cm 2 ) and UVA (1.5-6 J/cm 2 ) in uniform depth of medium (7 mm in 96 well plates, 5 mm in 24 well plates and 3.3 mm in 6 well plates). The effect of the depth of irradiation medium on UV-induced cell death was determined but was found to have no effect on cell survival in the range of 1.8-12 mm. For the determination of PARP activation, higher doses (2-4 J/cm 2 ) were also used, whereas for the proliferation assay, lower doses of UVB (0.0125-0.05 J/cm 2 ) have also been applied. The lid was removed from the plates before irradiation. Irradiation of HaCaT cells was carried out in phenol red free medium.
Cell viability and proliferation assay
Cell viability was determined with the MTT assay as previously described [20] . For the cell proliferation assay keratinocytes were grown to 70-80% confluency. Cells were then trypsinized, resuspended in the media, and counted. The cells were reseeded into 6-well tissue culture plates (2500 per well). After the pretreatment with PJ34 and 3AB and irradiation with UVB, the cells were incubated for 10 days. Fresh medium was added immediately after the irradiation, and on day 5. On day 10, medium was removed from the wells and cells were washed once with PBS. Half of the wells were stained with hematoxylin (Sigma-Aldrich, St. Louis, MO) for microscopic evaluation and the other half was stained for viability with MTT (Sigma-Aldrich, St. Louis, MO). hematoxylin-stained samples were photographed whereas MTT-stained samples were used for the quantification of cell proliferation (absorbance was measured at 590 nm after solubilization of the formazan crystals in DMSO).
LDH release assay
Lactate dehydrogenase released from damaged cells was measured with a commercial kit (Roche Applied Science, Mannheim, Germany). Briefly, microplates were centrifuged at 250 g for 10 min and the supernatants (100 μl) were transferred to 96-well flat bottom plates. Detection reagent (100 μl) was added, plates were incubated (30 min) and the absorbance of samples was measured at 490 nm.
Detection of caspase activation
Caspase-3 like activity was assessed by immunocytochemical detection of cleaved PARP-1 as detailed in Section 2.7.
Immunocytochemistry
PAR and cleaved PARP-1 were detected by immunocytochemistry. Cells were fixed in ice-cold methanol for 10 min at − 20°C and were rehydrated with 4 washes in PBS. After blocking endogenous peroxidase with 0.5% H 2 O 2 in methanol, non-specific binding was blocked by incubating coverslips in 1% BSA/PBS for 1 h. The cells were incubated for 1.5 h at room temperature with the primary antibodies: a monoclonal anti-PAR antibody (clone 10H, in 1:500 dilution) and a monoclonal cleaved hPARP-1 (Cell Signaling Technology, Danvers, MA, in 1:100 dilution). After 4 × 5 min washes in PBS, coverlips were incubated for 30 min at room temperature with peroxidase-conjugated rabbit/mouse secondary antibody (REAL Envision Detection System, Dako, Glostrup, Denmark). After washes, the peroxidase reaction was developed with 3,3-diaminobenzidine (DAB) substrate. Coverslips were viewed with a Zeiss Axiolab microscope (Carl Zeiss, Oberkochen, Germany). Pictures were taken with a Zeiss Axiocam digital camera. Samples processed with omission of the primary antibody served as negative control in the cleaved PARP-1 staining, whereas in the PAR staining the effect of PARP inhibitor treatment proved the specificity of the staining.
Mitochondrial membrane potential
The cells were seeded (2 × 10 6 /ml) into black 96-well plates. After the pretreatment and UVB irradiation, the incubation time was 24 h. Then the cells were loaded with 100 nM tetramethylrhodamine ethyl ester, TMRE, (Sigma-Aldrich, St. Louis, MO) for 20 min at 37°C. Cells were then washed with PBS, and TMRE fluorescence was measured with a fluorescence spectrophotometer (Fluoroskan FL, Thermo Scientific, Vantaa, Finland; ex 535 nm; em 590 nm).
Hydrogen peroxide production
Hydrogen peroxide production was determined with a fluorometric Amplex red assay kit (Invitrogen, Carlsbad, CA) following the instructions of the manufacturer. Cells were first irradiated with UVB or UVA followed by the addition of Amplex Red reagent (50 μM) and horse radish peroxidase (0.1 U/ml, Sigma-Aldrich). After incubation (30 min, 37°C), the fluorescence was measured with a fluorescence spectrophotometer (Fluoroskan FL, Thermo Scientific, Vantaa, Finland; ex 530 nm; em 590 nm).
Statistical analysis
All experiments were performed three times on different days. All the values shown on figures are expressed as mean ± S.E. of the mean of n observations where n represents the number of observations. Intergroup comparisons involved one-way ANOVA followed by Tukey's test (with equal variances assumed) or Dunnett's test (with equal variances not assumed). A p value less than 0.05 was considered as significant.
Results
Opposing effects of PJ34 and 3-aminobenzamide on UVB-induced toxicity
First we demonstrated that UVB (0.05-0.2 J/cm 2 ) caused a significant cytotoxicity in keratinocytes as determined in MTT viability tests ( Fig. 1A ). We set out to investigate the role of PARylation in UVB-induced keratinocyte death. Interestingly, only the benchmark PARP inhibitor 3AB but not the more potent PJ34 provided protection from UVB-induced suppression of viability ( Fig. 1) . At the dose of 0.1 J/cm 2 , PJ34 slightly sensitized cells to UVB-induced cell death (Fig. 1A) . The protection provided by 3AB was long lasting and cells saved by pretreatment with 3AB have not simply survived but maintained proliferative capacity as determined in long-term (10 days) proliferation assay ( Fig. 1B,C) . As opposed to the protective effect of 3AB, the potent and specific PARP inhibitor PJ34 sensitized cells to UVB-induced proliferation inhibition ( Fig. 1B, C) .
3-Aminobenzamide inhibits both apoptotic and necrotic cell death in UVB-irradiated keratinocytes
In severe oxidative stress models, activation of PARP-1 has been shown to switch apoptotic cell death towards necrosis [20, 21] . Here we have also investigated whether PARylation regulates the mode of cell death in UVB-treated keratinocytes. Morphology of May-Grünwald-Giemsa stained cells indicated that 0.2 J/cm 2 UVB irradiation caused apoptosis as indicated by smaller, condensed, picnotic nuclei ( Fig. 2A ). PJ34 sensitized cells to UVB-induced cell death as morphological alterations such as condensed apoptotic cells and also swollen necrotic cells appeared at lower UVB dose (0.1 J/cm 2 ). Pretreatment of cells with 3AB prevented these morphological alterations ( Fig. 2A) . Activity of caspases-3-like proteases, general executioners of apoptosis could be clearly demonstrated by immunodetection of cleaved PARP-1 (Fig. 2B ). PJ34 sensitized cells to apoptosis, whereas 3AB prevented it (Fig. 2) . Increased plasma membrane permeability as indicated for example by LDH release is a sign of necrotic cell death. UVB treatment caused a dose-dependent LDH release from keratinocytes (Fig. 2C ) which showed an overlapping pattern with the loss of viability (Fig. 2C ). Whereas PJ34 had no effect on LDH release, pretreatment with 3AB completely abolished plasma membrane disruption (Fig. 2C ).
3-Aminobenzamide prevents mitochondrial dysfunction in UVBirradiated keratinocytes
UVB induces ROS production leading to mitochondrial dysfunction (Kulms and Schwart 2002) . Here we show that UVB radiation triggered the production of hydrogen peroxide as determined in the Amplex red assay (Fig. 3A) . Moreover, UVB also induced mitochondrial depolarization (Fig. 3B ). Both H 2 O 2 production and the mitochondrial alterations were effectively blocked by 3AB but were not (or only very slightly) affected by PJ34 ( Fig. 3) .
The protective effect of 3-aminobenzamide is PARP independent
In order to elucidate the mechanism for the differential effects of the two PARP inhibitors we have also tested the effects of two additional potent and specific PARP inhibitors TIQ-A and DPQ. Similarly to PJ34, TIQ-A and DPQ also failed to protect keratinocytes from UVB-induced toxicity (Fig. S1 ). In fact all three potent PARP inhibitors slightly but significantly sensitized cells to UVB-induced cell death (Fig. S1) .
Interestingly, PARP activity of irradiated cells as measured by either the immunodetection of the PAR polymer (Fig. S2A ) or by the 3 H-NAD-based PARP enzyme assay (Fig. S2B ) could only be observed at UVB doses (2-4 J/cm 2 ) much higher than the cytotoxic dose (around 0.2 J/cm 2 ). At lower doses PAR polymer was not detectable (not shown). (Hydrogen peroxide treatment was used as a positive control.) Both the benchmark PARP inhibitor 3-aminobenzamide and the more potent and specific PARP inhibitor PJ34 prevented PAR synthesis proving the specificity of the assays.
In order to more directly assess the role of PARP-1, we silenced PARP-1 in the human HaCaT keratinocyte cell line (Fig. 4) . Expression of PARP-1 protein (Fig. 4A ) and synthesis of PAR polymer in response to hydrogen peroxide treatment (Fig. 4B ) was significantly reduced in the HaCaT-siPARP-1 cells as compared to the parent HaCaT cell line or the one transfected with control siRNA (HaCaT-siCTL cells). HaCaT cells displayed a lower sensitivity to UVB (Fig. 4C ) than the primary keratinocytes. Knockdown of PARP-1 resulted in sensitization of the cells to the toxic effects of UVB (Fig. 4D ). 3-Aminobenzamide effectively protected both HaCaT-siPARP-1 cells and HaCaT cells transfected with control siRNAs (HaCaT-siCTL cells) from UVB toxicity (Fig. 4D) . These data indicate that the photoprotective effects of 3AB are not due to PARP inhibition.
The photoprotective effect of 3AB is not restricted to UVB radiation
In order to find out whether our findings are restricted to UVB-irradiated cells, we have also investigated the effects of 3AB and PJ34 in the UVA response of keratinocytes. UVA-induced cell death was also differently regulated by 3AB and PJ34. Whereas PJ34 enhanced, 3AB suppressed UVA-induced loss of viability (Fig. 5A) , Fig. 3 . 3AB inhibits UVB-induced ROS production and mitochondrial dysfunction. NHEK cells were either left untreated or were pretreated with 10 μM PJ34 or 3 mM 3AB for 30 min followed by irradiation with the indicated doses of UVB. (A) Hydrogen peroxide production was determined after 60 min with Amplex red assay, and (B) mitochondrial inner membrane depolarization was assayed with the TMRE fluorescence method after 24 h. 3AB inhibited hydrogen peroxide production and prevented mitochondrial membrane depolarization. PJ34 had no effect on these parameters with the exception of a slight but statistically significant protection from mitochondrial depolarization induced by 0. morphological alterations such as cell compaction or swelling (Fig. 5B ), caspase activation (Fig. 5C ), LDH release ( Fig. 5D ) and hydrogen peroxide production ( Fig. 5E ).
Discussion
The most important environmental hazard damaging our skin is UV radiation with the UVB spectrum recognized as the most carcinogenic portion of solar radiation. Persistent photodamage triggers cell death in keratinocytes by co-ordinated execution of multiple cell death pathways [22] . These include a) clustering of death receptors (Fas, TNFR, TRAIL) initiating the extrinsic apoptotic pathway; and b) permeabilization of the mitochondrial outer membrane via ROS production and p38 MAP kinase activation (intrinsic route). UV-induced DNA damage may also elicit cell death via p53 activation (also via the intrinsic pathway) [23] .
Our hypothesis was that PARylation may represent an important regulatory mechanism in the UV response. PARylation has previously been shown in other cellular models to a) enhance cell survival after DNA damage; b) shift the mode of cell death from apoptosis to necrosis following severe DNA damage via NAD + /ATP depletion or AIF signaling; c) regulate both the p53 and NFκB pathways; d) become activated via MAP kinases; e) engage in a yet elusive relationship with the survival pathway mediated by Akt kinase; and f) regulate cellular metabolic activities [7, [24] [25] [26] [27] . Since all of these players and factors have been implicated in the regulation or modulation of the UV response, we set out to investigate the role of PARylation in UV-induced cell death.
Role of PARylation in keratinocyte survival following UVB radiation
We found that UVB activates PARylation but PARP activity and the PAR polymer has only become detectable at very high (2-4 J/cm 2 ) UV doses. However, it must be noted that the currently available methods assessing PARylation such as the PARP enzyme activity assay and detection of PAR polymer may underestimate PARP enzyme activity. The reason for this is that PARG may mask low level PARP activity by degrading the polymer that is detected in both assays used in the current study (PAR immunocytochemistry and PARP enzyme assay). In fact, the sensitizing effect of PJ34 or the knockdown of PARP-1 to apoptosis indicates that PARP-1 is activated at low UVB doses and may contribute to cell survival. Moreover, in other cell types we have also observed that PARG silencing increases the sensitivity of PAR detection/PARP activity [28] providing further support for our hypothesis that PARP is "latently" activated by lower UVB doses but this is masked by cellular PARG activity.
In our model, UVB radiation caused cell death with features of both apoptosis (picnotic nuclei, cell shrinkage and caspase activation) and necrosis (LDH release). (The latter may be secondary necrosis of primarily apoptotic cells as often seen in in vitro models). The benchmark PARP inhibitor 3AB provided remarkable protection from all of the cell death parameters measured. However, the more potent and specific PARP inhibitor PJ34 failed to rescue cells from UV-induced photodamage. On the contrary, PJ34 sensitized cells to apoptosis indicating that PARylation may contribute to the repair of UVB-induced DNA damage and thus facilitates keratinocyte survival. Since UVBinduced photoproducts are repaired by nucleotide excision repair (NER) this may indicate a role of PARylation in NER [4] . Indeed PARP-1 has been shown to bind to and become activated by thymine dimers in UV-irradiated fibroblasts [29] . Alternatively, the sensitizing effect of PJ34 to UVB-induced apoptosis may indicate the formation of ROS-induced DNA breaks that may be repaired by the PARP-dependent BER (base excision repair) machinery. The mechanism of UVB-induced PARP activation and the exact role of PARylation in the repair of UVB-induced DNA damage may require further investigation.
Photoprotection by 3-aminobenzamide
Based on the marked difference between the powerful cytoprotection provided by 3AB and the sensitization to apoptosis by the more potent and specific PARP inhibitor PJ34 and other new generation PARP inhibitors, we concluded that the cytoprotective effect of 3AB is not related to PARP inhibition. The PARP-1 independent nature of this cytoprotective effect was also supported by our data obtained in PARP-1 silenced HaCaT cells. These HaCaT-siPARP-1 cells were more sensitive to the toxic effects of UVB but 3AB provided significant protection to both control and HaCaT-siPARP-1 cells. These data clearly show that the cytoprotective effect of 3AB may not be due to PARP inhibition. 3AB is a weak PARP inhibitor (usually applied in the range of 1-10 mM) and is known to have additional pharmacological effects. For example it was shown to a) indirectly affect activation of protein kinase C [30] , act on the cytoskeleton [31] , scavenge hydroxyl radicals [32] and inhibit cytochrome P450 [33] . Thus 3AB appears to be a multifunctional agent possessing diverse pharmacological effects. The question arises where 3AB may interfere with cell death signaling in UVB-irradiated keratinocytes? Mitochondria represent a crucial checkpoint in the regulation of apoptosis by integrating survival and death signals [34] . Our data showing that 3AB prevents depolarization of the mitochondrial membrane indicates that 3AB acts at a step proximal to mitochondrial alterations. Furthermore, 3AB inhibited ROS production in UVB-irradiated cells which may explain its UV-protective effect. ROS production in UVB irradiated keratinocytes requires calcium mobilization [35] and 3AB has been shown to suppress ROS-induced calcium mobilization in other ROS mediated conditions [36] . However, this effect of 3AB is likely to be due to PARP inhibition as the effect can also be observed in PARP-1 knockout cells or in cells treated with other structurally unrelated PARP inhibitor [21] . The relationship between PARP activation and calcium signaling is even more complex as calcium signal has also been shown to be required for PARP activation and PARP-mediated cell death in oxidatively stressed HaCaT keratinocytes [37] and other cell types [38] .
The absorption spectrum of 3AB has a peak around the wavelength used for UVB irradiation (312 nm). Thus a sunscreen-like effect may partially be responsible for the UVB protective effect of 3AB. At 365 nm, however, the compound does not absorb light at all (data not shown), while it still very efficiently protected cells from UVA-induced damage. Since UVA-and UVB-induced cell death shared all morphological and biochemical features investigated, and the effects of the two inhibitors differed both in UVB and UVA-irradiated keratinocytes, therefore common mechanisms are likely to underlie cell death induced by UVA and UVB and to mediate the effects of PJ34 and 3AB. Since UVA was not absorbed by 3AB, the protective effect of the compound may thus be due to inhibition of a cell death pathway at a step proximal to mitochondrial dysfunction rather than acting as sunscreen.
PARylation in the regulation of the UV response in vivo?
Our results also have interesting in vivo implications. On the one hand, it may shed new light on the role of PARylation and the possible use of PARP inhibitors in UV-induced photoinjury, while on the other hand it suggests that 3AB may be a potential candidate for reducing photodamage in the skin. PARP inhibitors have been shown to exert potent anti-inflammatory effects in various models of inflammation ranging from shock, ischemia reperfusion injury to arthritis, colitis and uveitis [7, 39] . In many of these models, the cytoprotective (antinecrotic) effects of PARP inhibitors (or PARP-1 knockout) have been suggested to be responsible for at least part of the protective effects [7] . Our data demonstrating a lack of cytoprotection by PARP inhibitors in UVB-irradiated keratinocytes indicate that this mechanism may not be relevant in a putative anti-inflammatory effect of PARP inhibitors mainly because UVB-induced cell death is not typically necrotic in vivo. Based on the fact that PARP-1 is a co-factor of NF-κB, the master regulator of inflammatory gene expression [40, 41] , it is much more likely to be the key factor in the anti-inflammatory effects of PARP inhibitors. So far only one study addressed the role of PARP in photodamage [42] by using a multifunctional compound BGP15 that, in addition to possessing nNOS-inducing, HSP-inducing and insulin sensitizing effects, also inhibits PARP [43] [44] [45] . BGP-15 has been shown to reduce acute photodamage in mice [42] but the underlying mechanism may not be certain due to the diverse effects of the compound.
Our data also suggest that 3AB may have the potential to reduce UV-induced photodamage in vivo. By combining its potent and PARP-independent cytoprotective effect with PARP inhibitiondependent suppression of inflammatory mediators, it may exert powerful anti-inflammatory action. This hypothesis certainly requires further investigations which should also address (confirm or exclude) the potential mutagenic effect of 3AB resulting from the inhibition of apoptosis. Although it may be tempting to suggest that 3AB may be used as a photoprotective agent in vivo, data by Epstein and Cleaver [46] showing that topical application of 3AB shortened the time of onset of UVB-induced tumors and increased the number of tumors urge caution.
Supplementary data to this article can be found online at http:// dx.doi.org/10.1016/j.bbamcr.2012.12.003.
